H.C. Wainwright raised the firm’s price target on ChromaDex to $6 from $5 and keeps a Buy rating on the shares following the 2023 revenue beat. The analyst says double-digit revenue growth is likely going forward.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CDXC:
